ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 131,41
0,69%
Dow Jones
39 056,39
0,44%
DAX
18 498,38
0,32%
Brent Oil
83,735
0,21%
Bitcoin
61 526,57
0,55%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Gsk Plc (GSK)

  7. Gsk Plc (GSK) Actualités

GSK

Gsk (GSK)

Gsk Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:GSK
DateHeureSourceTitreSymboleSociété
08/05/202419h21RNS Regulatory NewsGSK PLC Result of AGMLSE:GSKGsk Plc
08/05/202417h57RNS Regulatory NewsGSK PLC Board Committee ChangeLSE:GSKGsk Plc
03/05/202416h30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
01/05/202416h00RNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
01/05/202409h50Alliance NewsAlliance NewsTOP NEWS: GSK expects momentum to continue after strong first quarterLSE:GSKGsk Plc
01/05/202408h00RNS Regulatory NewsGSK PLC 1st Quarter ResultsLSE:GSKGsk Plc
24/04/202410h14Alliance NewsAlliance NewsGSK's Jemperli with chemotherapy accepted for priority review by FDALSE:GSKGsk Plc
24/04/202408h00RNS Regulatory NewsGSK PLC US FDA accepts new indication filing for JemperliLSE:GSKGsk Plc
17/04/202409h46Alliance NewsAlliance NewsTOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatmentLSE:GSKGsk Plc
17/04/202408h05RNS Regulatory NewsGSK PLC GSK announces additional EAGLE-1 resultsLSE:GSKGsk Plc
17/04/202408h00RNS Regulatory NewsGSK PLC Results from long-term data relating to ShingrixLSE:GSKGsk Plc
16/04/202415h11RNS Regulatory NewsGSK PLC Amendment - Director/PDMR ShareholdingLSE:GSKGsk Plc
16/04/202409h59Alliance NewsAlliance NewsGSK's latest meningitis vaccine accepted for review by US regulatorLSE:GSKGsk Plc
16/04/202408h00RNS Regulatory NewsGSK PLC FDA accepts GSK meningitis vaccine candidate fileLSE:GSKGsk Plc
08/04/202411h27Alliance NewsAlliance NewsIN THE KNOW: Barclays ups GSK price target but HIV drug nerves remainLSE:GSKGsk Plc
04/04/202413h05RNS Regulatory NewsGSK PLC Replacement - Total Voting RightsLSE:GSKGsk Plc
25/03/202414h00RNS Regulatory NewsGSK PLC Notice of AGMLSE:GSKGsk Plc
22/03/202417h20RNS Regulatory NewsGSK PLC Transfer of Treasury SharesLSE:GSKGsk Plc
18/03/202410h30RNS Regulatory NewsGSK PLC New Phase III Jemperli data in endometrial cancerLSE:GSKGsk Plc
18/03/202409h47Alliance NewsAlliance NewsGSK says Jemperli combination gets good results for endometrial cancerLSE:GSKGsk Plc
07/03/202410h38Alliance NewsAlliance NewsGSK observes positive data in Blenrep trial for blood cancer treatmentLSE:GSKGsk Plc
07/03/202408h00RNS Regulatory NewsGSK PLC GSK announces positive Blenrep DREAMM-8 resultsLSE:GSKGsk Plc
06/03/202417h00RNS Regulatory NewsGSK PLC ViiV LAI vs oral SOC data in adherence-challengedLSE:GSKGsk Plc
05/03/202418h24RNS Regulatory NewsGSK PLC GSK Annual Report 2023 on Form 20-FLSE:GSKGsk Plc
05/03/202412h03Alliance NewsAlliance NewsGSK says ViiV's cabotegravir study supports longer HIV dose intervalLSE:GSKGsk Plc
05/03/202408h00RNS Regulatory NewsGSK PLC New ViiV LA formulation potential 4-month dosingLSE:GSKGsk Plc
01/03/202413h15RNS Regulatory NewsGSK PLC GSK publishes Annual Report 2023LSE:GSKGsk Plc
29/02/202410h44Alliance NewsAlliance NewsTOP NEWS: GSK avoids "protracted litigation" with Zantac settlementLSE:GSKGsk Plc
29/02/202408h05RNS Regulatory NewsGSK PLC Directorate ChangeLSE:GSKGsk Plc
29/02/202408h00RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
 Showing the most relevant articles for your search:LSE:GSK

Dernières Valeurs Consultées

EU
AF
Air FranceKLM
EU
VIV
Vivendi
EU
ML
Michelin
NYSE
MRK
Merck
EU
CS
Axa
EU
RI
Pernod Ricard
EU
MC
Lvmh Moet Hennessy Louis...
EU
AI
Air Liquide
NASDAQ
AMZN
Amazon.com
FTSE
UKX
FTSE 100
EU
VK
Vallourec
EU
EN
Bouygues
NYSE
JPM
JP Morgan Chase
EU
BEL20
Bel 20
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés